11 studies on Pinealon curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Verified Peptides | 5 | 99.55% | View COA → |
| Uther Peptide | 2 | 99.85% | View COA → |
| Uther Pharmaceutical | 2 | 99.84% | View COA → |
| Peptide Gurus | 2 | 99.23% | View COA → |
Recent certificates: #7661 (99.17%) · #15046 (98.911%) · #19771 (95.109%) · #19333 (99.563%) · #19239 (99.794%) · #19113 (99.537%)
Manufacturers with published third-party certificates of analysis for Pinealon. Open a vendor to see every batch we've verified.
These findings are significant as they highlight the potential of peptide preparations like Cortexin and Pinealon as geroprotective agents, capable of enhancing brain resilience against age-related stressors. By modul…
This research underscores the significant potential of specific oligopeptides, particularly the combination of Vezugen and Pinealon, as highly effective and safe geroprotective agents. The superior impact on biologica…
The introduction of the short peptides generally promoted a survival rate in animals subjected to carotid artery occlusion, though specific quantitative data for this improvement was not provided. > The study found th…
Pinealon's dual action of reducing oxidative stress and modulating cell proliferation highlights its potential as a therapeutic agent for conditions involving cellular damage and impaired regeneration. The finding tha…
This research confirms the neuroprotective properties of Pinealon, extending previous in vitro findings to an in vivo model of prenatal stress. The ability of Pinealon to protect against cognitive impairment and oxida…
This research suggests a novel strategy for maintaining the professional reliability and long-term health of individuals exposed to demanding work environments. The positive impact of Pinealon on biological age and ad…
This research highlights the significant potential of these bioregulatory tripeptides, particularly T-38, as novel agents for enhancing skin regeneration and combating age-related skin pathologies. The ability of T-38…
This research underscores the potential of peptide geroprotectors as novel therapeutic agents for combating age-related cognitive decline and neurodegenerative diseases. The finding that Pinealon exerts a prevalent po…
These findings are significant as they highlight the potential of specific peptides to mitigate the damaging effects of oxygen deprivation in the aging brain. Pinealon's capacity to both stimulate neurogenesis and red…
This research provides critical insights into the molecular mechanisms governing peptide-DNA interactions, particularly highlighting the significant and specific role of divalent ions like magnesium. Such detailed und…
The characterization of Pinealon as a neuroprotective tripeptide is highly significant, as it points towards a potential endogenous mechanism for maintaining brain health and resilience. This understanding could be fo…
Free, no account — handy when you're working with Pinealon.